Literature DB >> 17915073

Genetics and smoking behavior.

Robert A Schnoll1, Terrance A Johnson, Caryn Lerman.   

Abstract

Accumulating data support the role of genetic factors in smoking initiation, progression to tobacco dependence, and smoking persistence. This review summarizes current research on the heritability of tobacco use phenotypes and genetic association studies of smoking-related behaviors. Although progress has been made in genetics research on smoking behavior, many studies have methodological limitations, including insufficient samples for detecting gene-gene and gene-environment interactions and use of less refined phenotypes. Pharmacogenetic investigations also are identifying variants in drug-metabolizing enzymes, receptors, and transporters that modify therapeutic response to smoking cessation medications; however, the field is relatively new, and most findings in this area have yet to be replicated. As this research advances, it will be important to study and address practical, economic, ethical, and social barriers to the translation of genetics research on tobacco use to clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915073     DOI: 10.1007/s11920-007-0045-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  92 in total

1.  Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence.

Authors:  M A Silverman; M C Neale; P F Sullivan; C Harris-Kerr; B Wormley; H Sadek; Y Ma; K S Kendler; R E Straub
Journal:  Am J Med Genet       Date:  2000-10-09

Review 2.  Mimicking gene defects to treat drug dependence.

Authors:  E M Sellers; R F Tyndale
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

3.  A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence.

Authors:  Laura Jean Bierut; John P Rice; Alison Goate; Anthony L Hinrichs; Nancy L Saccone; Tatiana Foroud; Howard J Edenberg; C Robert Cloninger; Henri Begleiter; P Michael Conneally; Raymond R Crowe; Victor Hesselbrock; Ting-Kai Li; John I Nurnberger; Bernice Porjesz; Marc A Schuckit; Theodore Reich
Journal:  Am J Med Genet A       Date:  2004-01-01       Impact factor: 2.802

4.  Association between serotonin transporter gene polymorphism and smoking among Japanese males.

Authors:  H Ishikawa; T Ohtsuki; H Ishiguro; K Yamakawa-Kobayashi; K Endo; Y L Lin; H Yanagi; S Tsuchiya; K Kawata; H Hamaguchi; T Arinami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

5.  Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?

Authors:  Manfred Laucht; Katja Becker; Mahha El-Faddagh; Erika Hohm; Martin H Schmidt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 8.829

6.  A genome-wide screen for nicotine dependence susceptibility loci.

Authors:  Gary E Swan; Hyman Hops; Kirk C Wilhelmsen; Christina N Lessov-Schlaggar; Li S-C Cheng; Karen S Hudmon; Christopher I Amos; Heidi S Feiler; Huijun Z Ring; Judy A Andrews; Elizabeth Tildesley; Neal Benowitz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

7.  Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.

Authors:  Jacques Barik; Susan Wonnacott
Journal:  Mol Pharmacol       Date:  2005-11-03       Impact factor: 4.436

8.  Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.

Authors:  G E Swan; A M Valdes; H Z Ring; T V Khroyan; L M Jack; C C Ton; S J Curry; T McAfee
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

Review 9.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

10.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Authors:  Elaine C Johnstone; Patricia L Yudkin; Kate Hey; Sarah J Roberts; Sarah J Welch; Michael F Murphy; Siân E Griffiths; Robert T Walton
Journal:  Pharmacogenetics       Date:  2004-02
View more
  28 in total

1.  Interplay of Genetic Risk Factors and Parent Monitoring in Risk for Nicotine Dependence.

Authors:  Li-Shiun Chen; Eric O Johnson; Naomi Breslau; Dorothy Hatsukami; Nancy L Saccone; Richard A Grucza; Jen C Wang; Anthony L Hinrichs; Louis Fox; Alison M Goate; John P Rice; Laura J Bierut
Journal:  Addiction       Date:  2009-10       Impact factor: 6.526

2.  APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.

Authors:  Raj K Kalapatapu; Kevin L Delucchi
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

3.  Maternal smoking during pregnancy and risks of suicidal acts in young offspring.

Authors:  Sven Cnattingius; Tobias Svensson; Fredrik Granath; Anastasia Iliadou
Journal:  Eur J Epidemiol       Date:  2011-02-18       Impact factor: 8.082

4.  Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California.

Authors:  Dalin Li; Stephanie J London; Jinghua Liu; Wonho Lee; Xuejuan Jiang; David Van Den Berg; Andrew W Bergen; Denise Nishita; Nahid Waleh; Gary E Swan; Peggy Gallaher; Chih-Ping Chou; Jean C Shih; Jennifer B Unger; W James Gauderman; Frank Gilliland; C Anderson Johnson; David V Conti
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

5.  Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.

Authors:  Robert C Culverhouse; Li-Shiun Chen; Nancy L Saccone; Yinjiao Ma; Megan E Piper; Timothy B Baker; Laura J Bierut
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

Review 6.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

Review 7.  Pharmacogenetics and pharmacogenomics of anticancer agents.

Authors:  R Stephanie Huang; Mark J Ratain
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

8.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

9.  "I don't have to know why it snows, I just have to shovel it!": Addiction Recovery, Genetic Frameworks, and Biological Citizenship.

Authors:  Molly J Dingel; Jenny Ostergren; Kathleen Heaney; Barbara A Koenig; Jennifer McCormick
Journal:  Biosocieties       Date:  2017-07-11

10.  Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Authors:  Theresa M Marteau; Marcus R Munafò; Paul Aveyard; Chloe Hill; Sophia Whitwell; Thomas A Willis; Rachel A Crockett; Gareth J Hollands; Elaine C Johnstone; Alison J Wright; A Toby Prevost; David Armstrong; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMC Public Health       Date:  2010-11-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.